De Novo Autoimmune Hepatitis in Pediatric Liver Transplantation

What is the purpose of this trial?

The purpose of this study is to provide insights into the cause, development and effects of de novo autoimmune hepatitis so that prevention and treatment strategies can be developed in order to reduce post-liver transplant morbidity, the frequency of liver allograft loss and the need for re-transplantation.


Participation Guidelines

Ages: 3 months and older

Gender: Both


Yale University School of Medicine

Start Date: 03/15/2013

End Date: 12/12/2018

Last Updated: 03/07/2018

Study HIC#: 1302011561

Get Involved

For more information about this study, contact:
Danielle Paquette
+1 203-785-7526
danielle.paquette@yale.edu

If you would prefer to contact a member of the Help us Discover team about this trial and other similar trials, please email helpusdiscover@yale.edu or call 1-877-978-8348.

Trial Image

Investigators

Udeme D Ekong

Principal Investigator

Sub-Investigators